Post: VIVET ATTENDING 3RD ANNUAL GENE THERAPY FOR RARE DISORDERS CONFERENCE IN BOSTON

Post: VIVET ATTENDING 3RD ANNUAL GENE THERAPY FOR RARE DISORDERS CONFERENCE IN BOSTON

Jean-Philippe Combal, Vivet Therapeutics’ CEO, will be attending the 3rd Annual Gene Therapy for Rare Disorders conference in Boston (March 26-28 2019).

Latest events

J.P.Morgan 2024 – Annual Healthcare Conference in San Francisco

4 January 2024

Vivet spronsoring and attending the Spanish Wilson disease patients association annual conference in Valencia, Spain

15 November 2023

AASLD – The Liver Meeting in Boston

6 November 2023

ESGCT’s 30th Annual Congress in Brussels

24 October 2023

Wilson Disease Association’s Annual Conference

20 October 2023

Vivet presenting during the 6th annual Gene Therapy for Rare Disorders in Boston

20 March 2023